Cardiovascular Disease Introduction
Cardiovascular Disease Introduction
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Introduction: Cardiovascular Diseases Cardiovascular diseases represent one of the most important health challenges of the 21st century. Century and its causes are one of the leading death in the world. According to estimates by the world health organization (WHO), every year approximately 17.9 million deaths, nearly 32 % of all deaths globally. In Germany, they are also among the main reasons for mortality and morbidity, particularly heart attacks, strokes, and heart failure represent a high socio-economic burden. The term cardiovascular disease (including cardiovascular diseases) are summarized various diseases that affect the heart and blood vessel system. Among the most common forms: Coronary heart disease (CHD), caused by a narrowing of the coronary arteries due to atherosclerosis; Arterial hypertension, a chronically elevated blood pressure is considered a risk factor for other complications; Heart failure in which the heart can no longer pump enough blood into the circulation; Stroke (apoplexy), is caused by a circulatory disorder in the brain; Arrhythmias, irregular heart rhythms, which can lead to life-threatening conditions. The main causes for the emergence of cardiovascular disease are multifactorial and include both modifiable and non-modifiable risk factors. Among the modifiable factors: unhealthy diet (high, high in salt, fat and sugar content); lack of physical activity; Smoking and excessive alcohol consumption; Overweight and obesity; chronic Stress and psycho-social stress. Non-modifiable factors include age, gender (men are up to 50. Age at greater risk) and a family history. The prevention of cardiovascular disease, therefore, requires a holistic approach that focuses on the reduction of risk factors, early diagnosis and adequate therapy. By promoting good health as nutrition and exercise programs, awareness campaigns and improved supply structures — the burden of cardiovascular diseases is significantly lower. This introduction gives an Overview of the relevance that forms the main and the risk factors of cardiovascular diseases and forms the basis for a more detailed analysis of the individual diseases and their management strategies in the further course of the work. If you want, I can make a specific section in more detail, or other aspects (e.g., results of the latest research, statistics, or therapy approaches) to include!
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Cardiovascular Disease Introduction. All ingredients, such as garlic and cinnamon bark in Cardio Balance, have proved to reduce blood pressure. The combination of these ingredients in the right quantity has shown massive improvement in managing blood pressure.
Therapy of cardiovascular diseases
Diseases of the circulatory System hypertension
Exacerbation of cardiovascular diseases
Varicose veins is related to the cardiovascular diseases
https://rlls.ru/posts/212701-what-is-the-difference-between-the-hypertension-hypotension.html
https://remontspecteh.ru/posts/304477-what-are-the-tests-of-cardiovascular-diseases.html
Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon.
Oncological diseases of the cardiovascular system: epidemiology, pathogenesis and clinical implications Oncological diseases affecting the circulatory System, represent a heterogeneous group of diseases that include both primary tumors of the heart as well as secondary findings by metastases or treatment effects. Although such disorders are on the whole rare, you will have due to their potentially life-threatening complications of high clinical relevance. Epidemiology Primary cardiac tumors are rare and approximately 0.001 make–0.3% of all began the autopsy cases. Most of these tumors are benign; of these, approximately 50% are Myxomas, followed by lipomas, Papillomas and fibromas. Malignant heart tumors, especially sarcomas (e.g., Angiosarkome, Rhabdomyosarcoma), are significantly more rare and account for approximately 25% of primary cardiac tumors. Metastases in the area of the cardiovascular system, however, are significantly more common than primary tumors. They occur in about 10-15% of patients with systemic malignancies. Common primary tumors of the heart metastases are lung cancer, breast cancer, melanoma, and lymphoma. Pathogenesis and tumor types Primary benign tumors: Myxomas (usually in the left atrium localized) can cause valves to emboli, stenosis or insufficiency of the heart. Lipomas and fibromas are often asympomatisch, however, can cause a larger volume of mechanical complications. Malignant Tumors Primary: Angiosarkome are the most common Form of cardiac sarcomas and show an aggressive growth and early metastasis. Mesothelioma of the Pericardium are rare, however, effusions often to Pericardial and tamponade. Metastases: The most common localizations of the pericardium, the heart surface and, more rarely, the myocardial tissue. Pericardial metastases often lead to exudative perikardit halides, and pericardial tamponade. Clinical Symptoms Thief pendent of the tumor localization and size of the clinical symptoms vary greatly: Pericardial infection: pericarditis, Pericardial effusion, Tamponade (pressure, jugular vein congestion, Pulsus paradoxus). Atrial infestation (e.g., Myxoma): embolism (cerebral, or peripheral), heart valve insufficiency, dizziness, exertional dyspnoea. Ventricular Tumors: Congestive Heart Failure, Arrhythmias, Discharge Behind Containers. Coronary arteries metastases: Angina pectoris, myocardial infarction. Diagnostics The diagnostics includes: Echocardiography (TTE/TEE): first choice for the detection of tumors, and pericardial effusions. Magnetic resonance imaging (MRI): excellent tissue differentiation, and localization. Computer tomography (CT): for the assessment of Calcification and extra-cardiac Findings. PET‑CT: for the differentiation of benign and malignant processes and to search for the primary tumor. Biopsy: in unclear cases, the histological backup. Therapy Therapeutic strategies depend on the type of tumor: Surgical resection: a method of choice for inoperable benign tumors, and various sarcomas. Chemotherapy and radiation therapy for inoperable or metastatic malignancies. Palliative measures: pericardial window, Perikardzentese Aden in Tampon. Forecast The prognosis varies greatly: Benign tumors after complete resection have a favorable prognosis. Malignant tumors have a poor prognosis, with a media show survival time of 6-12 months after diagnosis. Summary Oncological diseases of the cardiovascular system are rare, but require early diagnosis and interdisciplinary treatment. Advances in imaging and surgical technique have improved the prognosis in an individual patient groups. Nevertheless, the therapy of malignant cardiac and vascular tumors is a challenge for medicine.